MDxHealth SA Ordinary Shares
MDXHUnited States
1 filed reports · 313 financial concepts · 4 earnings calls · 0 media appearances
Filed reports
1 reports · Dec 2025Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Annual · 20-FSEC EDGAR | 1 | 829 | Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2025 | 20-F | Dec 31, 2025 | Apr 3, 2026 | 829 | Open |
Financial data
313 concepts · 829 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial310 concepts · 815 facts · Dec 2023 to Dec 2025
- Accumulated depreciation, Ending balance12 · Dec 2023 to Dec 2025
- Lease liabilities10 · Dec 2023 to Dec 2025
- Accumulated amortization and impairment of intangible assets, Ending Balance6 · Dec 2023 to Dec 2025
- Annualized IFRS cost for existing warrants (in Dollars)6 · Dec 2023 to Dec 2025
- Cash and cash equivalents6 · Dec 2023 to Dec 2025
- Contingent Consideration, Ending balance6 · Dec 2023 to Dec 2025
- Effect on exchange rate changes6 · Dec 2023 to Dec 2025
- Ending balance6 · Dec 2023 to Dec 2025
- Equity6 · Dec 2023 to Dec 2025
- Gross value, Ending balance6 · Dec 2023 to Dec 2025
- Gross value, Ending balnce6 · Dec 2023 to Dec 2025
- Intangible asset gross, Ending Balance6 · Dec 2023 to Dec 2025
- Issued capital6 · Dec 2023 to Dec 2025
- Number of other equity instruments outstanding in sharebased payment arrangement6 · Dec 2023 to Dec 2025
- Share premium (IFRS)6 · Dec 2023 to Dec 2025
- Trade receivables6 · Dec 2024 to Dec 2025
- Unused tax losses for which no deferred tax asset recognised6 · Dec 2023 to Dec 2025
- Goodwill (IFRS)5 · Dec 2024 to Dec 2025
- Accruals classified as current4 · Dec 2024 to Dec 2025
- Assets and liabilities4 · Dec 2024 to Dec 2025
- Assets (IFRS)4 · Dec 2024 to Dec 2025
- Capital increase costs4 · Dec 2024 to Dec 2025
- Current assets4 · Dec 2024 to Dec 2025
- Current financial liabilities at amortised cost4 · Dec 2024 to Dec 2025
Product3 concepts · 14 facts · Dec 2023 to Dec 2025
- Revenue9 · Dec 2023 to Dec 2025
- Percentage of entitys revenue4 · Dec 2023 to Dec 2025
- Other revenue (IFRS)1 · Dec 2023
Segments
14 factsFigures broken down by business line, region, product or another axis the company reports on.
Products and services6 members · 14 facts
- Liquidbased Revenue3 · Dec 2023 to Dec 2025
- Royalties And Other Revenues3 · Dec 2023 to Dec 2025
- Tissuebased Revenue3 · Dec 2023 to Dec 2025
- GPS2 · Dec 2023 to Dec 2024
- Tissue Based Tests2 · Dec 2024 to Dec 2025
- Confirm Mdx1 · Dec 2023
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
4 calls · Nov 2025 to Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 13, 2026
- FY2026 Q1May 13, 2026
- FY2025 Q4Feb 26, 2026
- FY2025 Q3Nov 12, 2025
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.